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3,4-DihydropyrimidithionesAbstract We report herein, the usage of N,O-bis(trimethylsilyl)acetamide (BSA) and dicyclohexyl
carbodimide (DCC) as two new catalysts for three component condensation of an aldehyde, ethyl
acetoacetate and urea/thiourea under solvent free conditions at 100 C to afford the corresponding
3,4-dihydropyrimidine-2-(1H)-ones/thiones (DHPMs) in good to excellent yields. A comparative
study of these two catalysts was made and presented.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
In the recent decades, the developments of multi component
condensations (Ugi et al., 1994; Domling, 2006) (MCCs) are
of increasing importance in organic and medicinal chemistry
for modern drug discovery. It was soon established that
DHPMs exhibit similar therapeutic and pharmacological pro-
ﬁle to 1,4 dihydropyridines (DHPs) calcium channel modula-tor of the neﬁdine (Domling, 1998; Plunlett and Ellman,
1997; Schreiber, 2000). From the past two decades synthesis
of DHPMs and their derivatives being a hot area of research
due to their wide spectrum of biological activities (Bryzgalov
et al., 2006; Holla et al., 2004; Zorkun et al., 2006; Kappe,
1993, 1998, 2000a,b; Chitra et al., 2010; Atwal et al., 1991;
Rovnyak et al., 1992), including antibacterial, antiviral, antitu-
mor, anti-inﬂammatory, antiarrhythmic activity, antifungal
activities, and antihypertensive as well as the most potent
Ca2+ channel blockers (Rovnyak et al., 1995; Aswal et al.,
1990). Recently, inhibitors of the fatty acid transporter FATP4
(Christopher et al., 2006), one of the DHPMs derivative
monastrol has emerged as a new chemical tool for investigat-
ing human mitotic kinesin Eg5 (Emmanuel et al., 2007) motor
protein inhibitor for the development of anticancer drugs.
Furthermore, the marine alkaloids attributed to the dihydro
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Solvent free synthesis of 3,4-dihydropyrimidine-2-(1H)-ones/thiones S1741marine sources such as crambine, batzelladine B (potent HIV-
gp-120CD4 inhibitors) (Rama Rao et al., 1995).
The classical Biginelli reaction (Biginelli et al., 1888);
Kolosov et al., 2009) is the MCCs of aldehyde, ethyl acetoace-
tate and urea/thiourea reﬂuxed at100 C in ethanol, in the pres-
ence of acetic acid for 8 h. Several synthetic methodologies such
as solvent free (Weike, 2005; Bahrami et al., 2009; Besoluk
et al., 2008; Jing et al., 2009), ultrasounds (Yadav et al.,
2001), ionic liquids (Sushilkumar et al., 2004; Jiajian, 2001),
microwave synthesis (Kalyan Kumar, 2011; Kidwai et al.,
2002; Khabazzadeh et al., 2008), Green approach synthesis
(Ranu et al., 2002; Subhas et al., 2003; Raﬁee and Jafari,
2006; Zheng-Jun et al., 2009; Mridula et al., 2010), phase-trans-
fer catalysis (Bahar, 2009), baker’s yeast (Atu and Ram, 2007),
Brønsted acids (Yang et al., 2007; Shutalev and Sivova, 1998;
Renwei, 2006), Brønsted bases (Zhi-Liang et al., 2010), Lewis
acids (Ramalingan et al., 2008; Paraskar et al., 2003; Kumar
et al., 2001; Anil et al., 2007; Ma et al., 2000; Brindaban
et al., 2000; Zhua, 2004; Surya et al., 2005; Hamid Reza
et al., 2009), were developed to synthesize the 3,4 dihydro pyri-
midinones/thiones. Out of all these methodologies to the best of
our knowledge, there are two reports employing (PPh3) as a Le-
wis base (Debache et al., 2008). Herein, we report two new cat-
alysts viz. (a) BSA (N,O-bis-(trimethylsilyl)acetamide) (b) DCC
(dicyclohexyl carbodimide) for the synthesis of DHPMs under
solvent free conditions at 100 C, in an efﬁcient way, good to
excellent yields are obtained (Scheme 1).
2. Results and discussions
BSA and DCC are the two good moisture absorbents. These
two reagents were employed individually as a catalyst in the
Biginelli reaction to produce DHPMs from aromatic aldehyde,Table 1 Optimization of catalysts (BSA or DCC) under solvent fre






6 Solvent free 05
7 Solvent free 10
8 Solvent free 15
9 Solvent free 20
a Isolated yields of DHPMs with BSA.
b Isolated yields of DHPMs with DCC.ethyl acetoacetate and urea (4a-1 to 4j-1 and 4a-3 to 4j-3) or
thiourea (4a-2 to 4j-2 and 4a-4 to 4j-4). In an initial endower
the reaction was performed with 10 mole % of catalyst at
RT in different solvents viz. ethanol, methanol, tetrahydrofu-
ran, t-butanol, dioxan, acetonitrile and under solvent free con-
ditions. Even after 24 h the reaction was not moved at RT,
when the reaction temperature was raised to 100 C after
24 h only 20–30% of the product was obtained under solvent
free and catalyst free conditions. In the presence of BSA or
DCC catalyst yielded better results with low reaction times un-
der solvent free conditions. To optimize the amount of the cat-
alyst we have carried out the reaction with various mole % of
the catalysts. However there is no recognizable change in either
% of yield or the reaction time by the increased amounts in
catalysts over 10 mol % of both BSA and DCC (Table 1).
To elaborate the catalysts efﬁciency we have examined the
same reaction with other Brønsted bases, Lewis bases and Le-
wis acids under solvent free conditions the results are recorded
in (Table 2). To deﬁne the scope and limitations, the efﬁciency
of the catalysts (BSA and DCC) was examined with several
aldehydes, ethyl acetoacetate and urea/thiourea. Between these
two catalysts, the best results are produced with BSA. The ﬁnal
product (DHPMs) yields affected by the substitutions in the
benzene ring, electron withdrawing groups like nitro groups
leads relatively higher yields than electron donating groups like
alkyl, alkoxy and hydroxy groups (Table 3).e conditions.
Time (h) Yield (%)
X= O X= S
20 50a 47b 46a 42b
20 47a 45b 35a 39b
18 20a 27b 13a 17b
24 20a 15b 16a 13b
24 30a 33b 32a 32b
3–4 30a 15b 43a 12b
3–4 80a 71b 57a 54b
3–4 82a 68b 55a 51b
3–4 81a 70b 56a 55b
Table 2 Comparison of BSA/DCC catalyzed synthesis of
DHPMs with other basic and acidic catalysts.
Entry Catalyst Time (h) Yield (%)
1 t-BuOK 10–12 57a 55b
2 BSA 1.2–4 80a 57b
3 DCC 1.3–4 71a 54b
4 PPh3 10–12 30
a 29b
5 BF3et2O 6–8 43
a 40b
6 AlCl3 8–10 40
a 40b
7 Catalyst free 15–20 30a 20b
a Isolated yields of dihydro pyrimidinones.
b Isolated yields of dihydro pyrimidithiones.
Table 3 BSA or DCC catalyzed synthesis of 3, 4-dihydropyrimidin
Entry R-CHO Catalyst x Product Time (min)
1
OH







BSA O 4b-1 140
S 4b-2 180
DCC O 4b-3 170
S 4b-4 130
3 MeO BSA O 4c-1 140
S 4c-2 170
DCC O 4c-3 150
S 4c-4 180
4 Cl BSA O 4d-1 170
S 4d-2 200




BSA O 4e-1 100
S 4e-2 80





BSA O 4f-1 180
S 4f-2 220




BSA O 4g-1 140
S 4g-2 110
DCC O 4g-3 90
S 4g-4 110
8 OH BSA O 4h-1 260
S 4h-2 220





BSA O 4i-1 240
S 4i-2 260
DCC O 4i-3 290
S 4i-4 300
10 BSA O 4j-1 230
S 4j-2 260
DCC O 4j-3 230
S 4j-4 240
a Isolated yields,
b Melting points of 3,4-dihydropyrimidinone,
c Melting points of 3,4-dihydropyrimidithione.
S1742 Y.L.N. Murthy et al.The reaction may proceed via acylimine intermediate,
formed by the reaction of the aldehyde and urea/thiourea.
Subsequent addition of b-ketoester enolate to the acylimine,
followed by cyclization and dehydration by the catalysts
BSA or DCC, afforded the corresponding 3, 4-dihydropyri-
midinones/thiones. Schemes 2 and 3 were the deniable mecha-
nisms in the synthesis Biginelli 3,4-dihydropyrimidinones/
thiones. More recently similar kind of mechanism was ex-
plained by Debache et al. (2008), Slimi et al. (2016), Folkers
et al. (1932), Mamaev and Dubovenko (1970) and Valverde
et al. (2001).ones/thiones under solvent free conditions.
Yielda (%) Mp found Mp reference
80 182–183b
54 180–181c 184–186 (Besoluk et al., 2008)
71 183–184(Besoluk et al., 2008)
57
85
72 172–173b 175–177 (Bahrami et al., 2009)




72 150–152c 152–153 (Khabazzadeh et al., 2008)
61
90
81 208–210b 210–212 (Debache et al., 2008)
81 182–183c 184–185 (Debache et al., 2008)
80
87
85 210–212b 214–215 (Besoluk et al., 2008)
86 218–220c 219–221 (Besoluk et al., 2008)
74
88
79 200–202b 204–205 (Besoluk et al., 2008)
89 161–162c 163–164 (Besoluk et al., 2008)
75
90
75 229–230b 230–232 (Besoluk et al., 2008)
85 204–205c 206–207 (Besoluk et al., 2008)
73
85
87 234–235b 237–238 (Slimi et al., 2016)




78 200–201c 202–204 (Subhas et al., 2003)
72
90
78 200–202b 202–204 (Mridula et al., 2010)
















































Scheme 2 Plausible mechanism for the synthesis of 3,4-dihydropyrimidinones/thiones with DCC.
Solvent free synthesis of 3,4-dihydropyrimidine-2-(1H)-ones/thiones S17433. Conclusion
To sum up, we have developed novel methodologies for the syn-
thesis of DHPMs carried out by BSA/DCC under solvent free
conditions, excellent catalysts for one pot synthesis of dihydro-
pyrimidinones/thiones under solvent free conditions, short reac-
tion time, high yields of products, simple work up procedures
and easy isolation making it an important supplement to the
existing methods. Further, we are studying the scope of these
catalysts to the other organic multicomponent reactions.
4. Experimental
4.1. General procedure for synthesis of 3,4-
dihydropyrimidinones/thiones under solvent free conditions
Aromatic aldehyde (0.01 moles), ethyl acetoacetate (0.012 mo-
les) and urea/thiourea (0.01 moles) were stirred at 100 C in the
presence of BSA/DCC (10 mol %) for 110–300 min, the reac-
tion was monitored by thin layer chromatography (TLC)
[6:4 hexane–ethyl acetate]. After the completion of the reaction
the reaction mixture was cooled and washed with ice cooled
water, the separated solid was ﬁltered and dried in vacuum,
the solid product passed over a column of silica gel (60–100
mesh), ﬁnally recrystallized from alcohol to afford the desired
product in pure form. Melting points were measured on Pol-mon melting point apparatus Mp 96. IR spectra were recorded
on a Shimadzu IR Afﬁnity-1. 1H and 13C NMR spectra were
recorded on a Bruker DRX 200 spectrometer and 50 MHz,
respectively. NMR spectra were obtained on solutions in
CDCl3 and DMSO-d6. Mass spectra were recorded on water
XEVO QTof mass spectrometer.
4.2. 4-(3-Hydroxy-phenyl)-6-methyl-2-thioxo-1,2,3,4-
tetrahydro-pyrimidine-5-carboxylicacid ethyl ester (4a-2)
Mp 182–183 C; IR (KBr): 3423, 3095, 2920, 2823, 1719, 1658,
1517 cm1; 1H NMR (200 MHz, DMSO-d6): d 1.16 (t,
J= 7.2 Hz, 3H OCH2CH3), 2.21 (s, 3H, CH3), 4.02 (q,
J= 7.2 Hz, 2H, OCH2CH3), 5.17 (d, J= 3.0 Hz, 1H, CH-
Ar), 6.81 (s, 1H, Ar-H), 6.90 (d, J = 8.2 Hz, 1H, Ar-H), 7.11
(d, J= 7.2 Hz, 1H, Ar-H), 7.25–7.35 (m, 1H, Ar-H) 7.28 (d,
J= 8.2 Hz), 7.24 (br s, N–H), 8.90 (br s, N–H), 9.15 (s, 1H,
OH); 13C NMR (50 MHz, DMSO-d6): d 174.5, 165.2, 157.2,
144.8, 144, 129, 117.3, 114.9, 113.6, 102.3, 59.5, 54.7, 17.5,
13.9; EIMS: m/z [M+1]+: 292.
4.3. 4-(3Hydroxy-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-
pyrimidine-5-carboxylicacid ethyl ester (4a-1)
Mp 180–181 C; IR (KBr): 3512, 3352, 3244, 3119, 2980, 1718,


















































Scheme 3 Plausible mechanism for the synthesis of 3,4-dihydropyrimidinones/thiones with BSA.
S1744 Y.L.N. Murthy et al.(200 MHz, DMSO-d6): d 1.12 (t, 3H, J= 7.2 Hz, CH3), 2.24
(s, 3H, CH3), 3.99 (q, 2H, J = 7.2 Hz, OCH2–CH3), 5.07 (d,
1H, J= 3.0 Hz, CH-Ar), 6.61–6.68 (m, 3H, Ar-H), 7.09 (t,
1H, J= 8.0 Hz, Ar-H), 7.68 (s, 1H, NH), 9.15 (s, 1H, OH),
9.35 (s, 1H, NH); 13C NMR (50 MHz, DMSO-d6): d 165.8,
157.8, 152.7, 148.5, 146.7, 129.7, 117.3, 114.6, 113.5, 99.9,
59.7, 54.3, 18.2,14.6; EIMS m/z [M+1]+: 277.11.
4.4. 4-(3,4-Dimethoxy-phenyl)-6-methyl-2-oxo-1,2,3,4-
tetrahydro-pyrimidine-5-carboxylicacid ethyl ester (4b-1)
Mp 171–173 C; IR (KBr): 3350, 3220, 3190, 2984, 1668, 1650,
1620 cm1; 1H NMR (200 MHz, DMSO-d6): d 1.15(t,
J = 8.2 Hz, 3H OCH2CH3), 2.14(s, 3H, CH3), 3.86 (s, 6H,
2·OCH3), 4.01(q, J = 8.2 Hz, 2H, OCH2CH3), 5.20(d,
J = 3.0 Hz, 1H, CH-Ar), 6.78–6.82 (m,3H, Ar-H), 7.15(br s,
N–H), 8.90(br s, N–H); 13C NMR (50 MHz, DMSO-d6): d
164.6, 152.7, 152.1, 147.6, 147.1, 136.3, 117.5, 110.2, 109.2,
98.5, 58.5, 54.9, 53.2, 24.7, 14.0; EIMS: m/z [M+1]+: 321.
4.5. 4-(4-Methoxy-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-
pyrimidine-5-carboxylicacid ethyl ester (4c-1)
Mp 201–202 C; IR (KBr): 3223, 3095, 2929, 2833, 1710, 1655,
1512 cm1; 1H NMR (200 MHz, DMSO-d6): d 1.15(t,
J = 7.2 Hz, 3H CH3), 2.24 (s, 3H, CH3), 3.80 (s, 3H, OCH3),
4.01 (q, J = 8.2 Hz, 2H, OCH2CH3), 5.18 (d, J = 3.0 Hz, 1H,
CH-Ar), 6.88 (d, J = 8.2 Hz, 2H, Ar-H), 7.28 (d, J = 8.2 Hz),
7.24 (br s, N–H), 8.90(br s, N–H); 13C NMR (50 MHz,
DMSO-d6): d 165, 158.8, 152, 147.7, 137, 127.1, 113.7, 97.8,
58.6, 54.6, 53.4, 17.6, 13.9; EIMS: m/z [M+1]+: 291.4.6. 4-(4Chloro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-
pyrimidine-5-carboxylicacid ethyl ester (4d-1)
Mp 217–218 C; IR (KBr): 3237, 3117, 2978, 1701, 1647, 1460,
1288, 1221, 1088, 781 cm1; 1H NMR (200 MHz, DMSO-d6):
d 1.09 (t, 3H, J = 7.2 Hz, OCH2–CH3), 2.25 (s, 3H, CH3),
3.98 (q, 2H, J = 7.2 Hz, OCH2–CH3), 5.14 (d, 1H,
J = 3.0 Hz, CH-Ar), 7.25 (d, 2H, J = 8.4 Hz, Ar-H), 7.39 (d,
2H, J = 8.4 Hz, Ar-H), 7.77 (s, 1H, NH), 9.24 (s, 1H, NH);
13C NMR (50 MHz, DMSO-d6): d 165.7 152.4, 149, 144.3,
132.2, 128.9, 128.6, 99.3, 59.7, 53.9, 18.3, 14.5; EIMS: m/z
[M+1]+ 295.08.
4.7. 4-(2Chloro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-
pyrimidine-5-carboxylicacid ethyl ester (4e-1)
Mp 223–224 C; IR (KBr): 3354, 3223, 3107, 2978, 1694, 1639,
1450, 1368, 1230, 1098, cm1;1H NMR (200 MHz, DMSO-d6):
d 0.97 (t, 3H, J = 7.2 Hz, CH3). 2.28 (s, 3H, CH3), 3.87 (q, 2H,
J = 7.2 Hz, OCH2–CH3), 5.61 (d, 1H, J = 2.8 Hz, CH-Ar),
7.24–7.40 (m, 4H, Ar-H), 7.68 (s, 1H, NH), 9.25 (s, 1H,
NH); 13C NMR (50 MHz, DMSO-d6): d 165.4, 151.8, 149.8,
142.2, 132.1, 129.8, 129.5, 129.2, 128.2, 98.3, 59.5, 51.9, 18.1,
14.4, EIMS: m/z [M+1]+: 295.08.
4.8. 4-(2,4-Dimethoxy-phenyl)-6-methyl-2-oxo-1,2,3,4-
tetrahydro-pyrimidine-5-carboxylicacid ethyl ester (4f-1)
Mp 200–202 C; IR (KBr): 3223, 3095, 2929, 2833, 1710, 1655,
1512 cm1; 1H NMR (200 MHz, DMSO-d6): d 1.15 (t,
J = 7.2 Hz, 3H CH3), 2.24 (s, 3H, CH3), 3.81 (s, 3H,
Solvent free synthesis of 3,4-dihydropyrimidine-2-(1H)-ones/thiones S1745OCH3), 3.85 (s, 3H, OCH3), 4.01 (q, J = 8.2 Hz, 2H,
OCH2CH3), 5.18 (d, J = 3.2 Hz, 1H, CH-Ar), 6.38 (d,
J= 7.8 Hz, 2H, Ar-H), 7.28 (s, 1H, Ar-H), 6.80 (br s, N–H),
6.90 (d, J = 7.8 Hz, 2H, Ar-H), 9.00 (br s, N–H); 13C NMR
(50 MHz, DMSO-d6); d 164.6, 153.7, 152.1, 148.6, 147.1,
136.3, 116.5, 112.2, 105.2, 98.5, 59.5, 54.9, 53.2, 23.7, 13.0.
EIMS: m/z [M+1]+: 320.
4.9. 4-(3-Nitro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-
pyrimidine-5-carboxylic acid ethyl ester (4g-1)
Mp 229–230 C; IR (KBr): 3238, 3123, 2986, 1730, 1705, 1645,
1522, 1348, 1219, 1096, 854, 783 cm1; 1H NMR (200 MHz,
DMSO-d6): d 1.10 (t, 3H, J = 7.2 Hz, CH3), 2.27 (s, 3H,
CH3), 3.99 (q, 2H, J = 7.2 Hz, OCH2–CH3), 5.27 (d, 1H,
J = 3.0 Hz, CH-Ar), 7.50 (d, 2H, J = 8.6 Hz, Ar-H), 7.89 (s,
1H, NH), 8.22 (d, 2H, J = 8.6 Hz, Ar-H), 9.35 (s, 1H, NH);
13C NMR (50 MHz, DMSO-d6): d 165.5, 152.5,
152.2149.9147.2 128.1, 124.3, 98.6, 59.9, 54.1, 18.3,14.5; EIMS
m/z [M+1]+: 306.10.
4.10. 4-(4-Hydroxy-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-
pyrimidine-5-carboxylic acid ethyl ester (4h-1)
Mp 234–235 C; IR (KBr): 3235, 3113, 2955, 1703, 1647, 1514,
1456, 1279, 1221, 1088, 837, 791 cm1; 1H NMR (200 MHz,
DMSO-d6): d 1.10 (t, 3H, J = 7.2 Hz, CH3); 2.25 (s, 3H,
CH3), 3.98 (q, 2H, J = 7.2 Hz, OCH2–CH3), 5.09 (d, 1H,
J = 3.0 Hz, CH-Ar), 6.87 (d, 2H, J = 8.6 Hz, Ar-H), 7.15
(d, 2H, J = 8.6 Hz, Ar-H), 7.67 (s, 1H, NH), 9.13 (s, 1H,
NH); 13C NMR (50 MHz, DMSO-d6): d 166.8, 157.9, 150.6,
147.5, 136.5, 125.9, 112.2, 100.0, 56.5, 53.8, 18.2, 15.6; EIMS
m/z [M+1]+: 277.12.
4.11. 4-(3,4,5-Trimethoxy-phenyl)-6-methyl-2-oxo-1,2,3,4-
tetrahydro-pyrimidine-5-carboxylic acid ethyl ester (4i-1)
Mp 171–173 C; IR (KBr): 3350, 3220, 3190, 2984, 1668, 1650,
1620 cm1;1H NMR (200 MHz, DMSO-d6): d 1.15 (t,
J = 7.2 Hz, 3H OCH2CH3), 2.14 (s, 3H, CH3), 3.86 s, 9H,
3xOCH3), 4.01 (q, J = 7.2 Hz, 2H, OCH2CH3), 5.20 (d, 1H,
J = 3.0 Hz, CH-Ar), 6.78–6.82 (m, 3H, Ar-H), 7.15 (br s,
N–H), 8.90 (br s, N–H); 13C NMR (50 MHz, DMSO-d6): d
164.6152.3, 152.7, 152.1, 147.6, 147.1, 136.3, 117.5, 110.2,
109.2, 98.5, 58.5, 54.9, 53.2, 24.7, 14.0; EIMS: m/z[M+1]+:
320.
4.12. 4Phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-
carboxylic acid ethyl ester (4j-1)
Mp 202–204 C; IR (KBr): 3256, 3121, 2945, 1730, 1703, 1647,
1464, 1290, 1226, 1090, 756 cm1; 1H NMR (200 MHz,
DMSO-d6): d 1.09 (t, 3H, J = 7.0 Hz, CH3); 2.25 (s, 3H,
CH3), 3.98 (q, 2H, J = 7.0 Hz, OCH2–CH3), 5.15 (d, 1H,
J = 3.2 Hz, CH-Ar), 7.21–7.35 (m, 5H, Ar-H), 7.73 (s, 1H,
NH), 9.19 (s, 1H, NH); 13C NMR (50 MHz, DMSO-d6): d
165.8, 152.6, 148.8, 145.3, 128.8, 127.7, 126.7, 99.7, 59.6,
54.4, 18.2 14.5; EIMS m/z [M+1]+: 261.12.References
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